There were no differences between COPD and non-COPD ASM cells in the deposition of FBLN-1 or FN either basally or after treatment with TGF-β1 (Fig. 1A, Fig. E1A). This evidence concerns the gene FN1 and chronic obstructive pulmonary disease.